Diana Čekatauskaitė

Associate Director, Business Development at Synaffix BV

Diana Čekatauskaitė is an accomplished business developer with a background in biomedical research and bioentrepreneurship. As part of the Business Development team at Synaffix, she played a key role in transforming the company from a university spin-out into a leading antibody-drug conjugate technology provider which was acquired by the Swiss conglomerate Lonza in 2023. With experience in venture investment, management consulting, and scientific research, Diana specializes in translating life science innovations into commercial success.